NYSE$DHR
Danaher Corp · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Danaher's first quarter performance was driven by positive results across all three reporting segments, with Cepheid, Radiometer, Pall, and ChemTreat businesses showing particular strength.
Danaher Corporation reported a 3.0% increase in revenues to $4.3 billion for the first quarter of 2020, with net earnings of $595.1 million, or $0.81 per diluted common share. Non-GAAP adjusted diluted net earnings per common share were $1.05, and core revenue growth was 4.5%. The company also closed its acquisition of the GE Biopharma business, now called Cytiva, on March 31.
- Delivered 4.5% core revenue growth.
- Closed acquisition of GE Biopharma business (Cytiva) on March 31.
- Providing diagnostic testing capabilities and supporting the pursuit of new treatments and vaccines for COVID-19.
- Well-positioned to navigate through the uncertain environment due to a strong portfolio, exceptional team, and disciplined execution.
Headline financials
Revenue & EPS history
Danaher · Revenue · Quarterly
$4.34B
Forward guidance
For the second quarter of 2020, Danaher anticipates that non-GAAP core revenue growth including Cytiva will be in the range of approximately flat to down 10%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
+0.0%
Avg return
Earnings day
+0.0%
Avg return
5 days after
+0.3%
Avg return
30 days after
42%
31 / 73 earnings
Positive
+7.0%
Q4 2020
Best reaction
-9.7%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -9.0% | -12.2% | |
| Q4 2025 | -5.4% | -7.5% | -11.6% | |
| Q3 2025 | +6.1% | +7.0% | +6.6% | |
| Q2 2025 | -0.4% | +5.2% | -4.0% | |
| Q1 2025 | +3.8% | +6.6% | +1.4% | |
| Q4 2024 | -9.7% | -11.1% | -17.9% | |
| Q3 2024 | -5.9% | -9.8% | -13.6% | |
| Q2 2024 | +5.9% | +9.2% | +6.8% | |
| Q1 2024 | +6.1% | +4.4% | +10.7% | |
| Q4 2023 | +2.6% | +5.7% | +9.7% | |
| Q3 2023 | -5.6% | -7.9% | +8.5% | |
| Q2 2023 | +2.7% | +0.8% | -1.7% | |
| Q1 2023 | -8.6% | -6.9% | -9.4% | |
| Q4 2022 | -5.1% | -4.0% | -8.8% | |
| Q3 2022 | -5.2% | -2.3% | +1.1% | |
| Q2 2022 | +7.0% | +8.0% | +14.2% | |
| Q1 2022 | -5.6% | -10.5% | -10.2% | |
| Q4 2021 | +5.4% | +5.4% | +3.0% | |
| Q3 2021 | -0.5% | -2.5% | -0.2% | |
| Q2 2021 | +4.1% | +3.9% | +14.9% | |
| Q1 2021 | +6.3% | +5.6% | +3.3% | |
| Q4 2020 | +7.0% | +3.3% | -6.1% | |
| Q3 2020 | +2.7% | +5.8% | -0.3% | |
| Q2 2020 | -0.2% | +1.7% | +6.2% | |
| Q1 2020 | -0.6% | -1.7% | +5.3% | |
| Q4 2019 | -2.6% | -1.5% | -12.5% | |
| Q3 2019 | -1.9% | -0.9% | +3.5% | |
| Q2 2019 | +1.4% | +2.0% | +0.5% | |
| Q1 2019 | +1.6% | +2.3% | +5.0% | |
| Q4 2018 | +2.8% | +2.8% | +18.9% | |
| Q3 2018 | -4.4% | -7.2% | -1.7% | |
| Q2 2018 | +2.5% | +4.8% | +2.0% | |
| Q1 2018 | -1.0% | -2.2% | -1.1% | |
| Q4 2017 | -2.3% | -1.6% | -5.8% | |
| Q3 2017 | +5.5% | +5.7% | +8.4% | |
| Q2 2017 | -3.2% | -4.4% | -5.7% | |
| Q1 2017 | -5.5% | -3.6% | -5.0% | |
| Q4 2016 | +4.0% | +3.4% | +7.8% | |
| Q3 2016 | +3.9% | +2.1% | +2.4% | |
| Q2 2016 | -0.2% | +0.2% | -0.8% | |
| Q1 2016 | +1.6% | — | — | |
| Q4 2015 | -0.2% | — | — | |
| Q3 2015 | +4.2% | — | — | |
| Q2 2015 | -0.1% | — | — | |
| Q1 2015 | -2.3% | — | — | |
| Q4 2014 | -1.0% | — | — | |
| Q3 2014 | +3.9% | — | — | |
| Q2 2014 | -4.3% | — | — | |
| Q1 2014 | -0.2% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | +4.1% | — | — | |
| Q2 2013 | +0.4% | — | — | |
| Q1 2013 | -1.1% | — | — | |
| Q4 2012 | -1.2% | — | — | |
| Q3 2012 | -4.9% | — | — | |
| Q2 2012 | -1.9% | — | — | |
| Q1 2012 | -2.8% | — | — | |
| Q4 2011 | -0.6% | — | — | |
| Q3 2011 | +6.4% | — | — | |
| Q2 2011 | -3.1% | — | — | |
| Q1 2011 | -2.1% | — | — | |
| Q4 2010 | +1.8% | — | — | |
| Q4 2007 | +1.8% | — | — | |
| Q3 2010 | +3.8% | — | — | |
| Q2 2010 | -4.4% | — | — | |
| Q1 2009 | +4.8% | — | — | |
| Q1 2010 | +0.4% | — | — | |
| Q4 2009 | -0.1% | — | — | |
| Q3 2009 | -0.8% | — | — | |
| Q3 2008 | -0.8% | — | — | |
| Q2 2009 | -2.4% | — | — | |
| Q2 2008 | -2.4% | — | — | |
| Q4 2008 | -2.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro